SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Aspauza Jossie

(Last)

(First)

(Middle)

800 W. OYMPIC BLVD.

SUITE 406

(Street)

LOS ANGELES

90015

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/30/2014

3. Issuer Name and Ticker or Trading Symbol
HERBALIFE LTD. [ HLF ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, SAM/CAM

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,248	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Appreciation Rights	⁽¹⁾	12/31/2017	Common Stock	3,600	$20.14	D
Stock Appreciation Rights	⁽²⁾	02/28/2018	Common Stock	600	$21.56	D
Stock Appreciation Rights	⁽³⁾	02/27/2019	Common Stock	1,840	$6.82	D
Stock Appreciation Rights	⁽⁴⁾	05/07/2020	Common Stock	1,854	$22.94	D
Stock Appreciation Rights	⁽⁵⁾	05/18/2021	Common Stock	2,257	$53.29	D
Stock Appreciation Rights	⁽⁶⁾	05/31/2022	Common Stock	5,409	$44.79	D
Stock Appreciation Rights	⁽⁷⁾	09/01/2022	Common Stock	453	$48.39	D
Stock Appreciation Rights	⁽⁸⁾	12/19/2023	Common Stock	2,512	$79.58	D
Stock Appreciation Rights	⁽⁹⁾	04/30/2024	Common Stock	3,752	$59.98	D

Explanation of Responses:

1. These stock appreciation rights were fully vested as of December 31, 2010.

2. These stock apprecation rights were fully vested as of February 28, 2011.

3. These stock apprecation rights were fully vested as of February 27, 2012.

4. These stock appreciation rights were fully vested as of May 7, 2013.

5. These stock appreciation rights were fully vested as of May 18, 2014.

6. 40% of these stock appreciation rights were vested as of May 31, 2014 and the remaining 60% will vest May 31, 2015.

7. 40% of these stock appreciation rights were vested as of September 1, 2014 and the remaining 60% will vest September 1, 2015.

8. 20% of these stock appreciation rights vested on June 21, 2014, 20% will vest June 21, 2015 and the remaining 60% will vest June 21, 2016.

9. 20% of these stock appreciation rights will vest April 30, 2015, 20% will vest April 30, 2016 and the remaining 60% will vest April 30, 2017.

Remarks:

	Jossie Aspauza by Jim Berklas, Attorney-in-Fact	11/07/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.